Evaluation of using botulinum toxin (A) in the treatment of myofacial pain syndrome

Bell, 1969, Clinical diagnosis of the pain dysfunction syndrome, J Am Dent Assoc, 79 El Beialy, 1988 Laskin, 1969, Etiology of the pain dysfunction syndrome, J Am Dent Assoc, 79 Schwartz, 2000, Botulinum toxin: new treatment for temporomandibular disorders, Br J Oral Maxillofac Surg, 38, 466, 10.1054/bjom.1999.0238 Copeland, 2001, 230 Clark, 2005, Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis, Plast Reconstr Surg, 573, 10.1097/01.PRS.0000150149.74749.55 Bradly, 1987, Conservative treatment for tempromandibular joint pain dysfunction, Br J Oral Maxillofac Surg, 125, 10.1016/0266-4356(87)90007-6 Freund, 1998, The use of botulinum toxin for the treatment of temporomandibular disorder, Oral Health, 88, 32 Schult-Mattler, 1999, Treatment of tension type headache by botulinum toxin: a pilot study, Eur J Med Res, 4, 183 Silbersation, 2000, Botilinum toxin type A as a main preventive treatment, Headache, 40, 445, 10.1046/j.1526-4610.2000.00066.x Okeson, 1998, 144 Khder, 1998, The effect of using laser in the treatment of myofacial pain dysfunction syndrome, Egypt Dent J, 44, 3494 Helkimo, 1974, Studies of function & dysfunction of the masticatory system, Suedish Dent J, 67, 1 Fricton, 1986, Reliability of craniomandibular index, J Dent Res, 65, 1359, 10.1177/00220345860650111701 Da Cunba, 2007, Analysis of helkimo and craniomandibular indexes for TMJ disorders, Rev Bras Otorinolaringol, 73, 19 Widmer, 1989, Temporomandibular joint sounds: a critique of techniques for recording and analysis, J Craniomandib Disord, 4, 213 Woo Seog, 2011, Application of botulinum toxin in pain management, Korean J Pain, 24, 1, 10.3344/kjp.2011.24.1.1 Cheshire, 1994, Botulinum toxin in the treatment of myofacial pain syndrome, Pain, 59, 65, 10.1016/0304-3959(94)90048-5 Lim, 2008, Review description of injection technique, Acta Neurol Scand, 117, 73 Freund, 2003, Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations, Br J Oral Maxillofac Surg, 41, 351, 10.1016/S0266-4356(03)00129-3 Babadag, 2004, Pre- and post treatment analysis of clinical symptoms of patients with tempromandibular disorders, Quintessence Int, 35, 811 Syrop, 2002, Initial management of temporomandibular disorders, Dent Today, 21, 52 Kim, 2005, Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement, Dermatol Surg, 29, 484 Vani, 2008, Temporomandibular disorders, N Engl J Med, 359, 2693, 10.1056/NEJMra0802472 De Laat, 2003, Counseling and physical therapy as treatment for myofascial pain of the masticatory system, J Orofac Pain, 17, 42 Okeson, 2008 Klasser, 2009, Oral appliances in the management of temporomandibular disorders, Oral Surg Oral Med Oral Med Oral Pathol Oral Radiol Endod, 107, 212, 10.1016/j.tripleo.2008.10.007 Carvajal, 2000, Long-term evaluation of MPDS, J Oral Maxillofac Surg, 58, 852, 10.1053/joms.2000.8201 Venancio-Rde, 2008, Different substances and dry-needling injection in patients with myofacial pain and headaches, Cranio, 26, 96, 10.1179/crn.2008.014 Yang, 2005, DMR:EMG applied to the diagnosis of MPDS and TMJ disorders, Int J Oral Maxillofac Surg, 34, 733, 10.1016/j.ijom.2005.02.011 2002, Botulinum toxin type A in the management of oromandibular dystonia and bruxism, 343 Ferrario, 2006, The influence of occlusion on jaw and neck muscle activity: a surface EMG study in healthy young adults, J Oral Rehabil, 33, 341, 10.1111/j.1365-2842.2005.01558.x Gordon, 2008, Botulinum toxin type A in pain management, Pract Pain Manag Karacalar, 2005, Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: clinical experience, J Craniofac Surg, 16, 476, 10.1097/04.SCS.0000157263.73768.64 Isberg, 1985, Clinical, radiographic, and electomyographic study of patient with internal derangement of the temporomadnibular joint, Am J Orthod, 88, 453, 10.1016/S0002-9416(85)80044-0 Clark, 1999, The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings, J Oral Maxillofac Surg, 57, 920, 10.1016/S0278-2391(99)90008-3 Isaac, 2000, Unilateral temporalis muscle hypertrophy managed with botulinum toxin type A, Br J Oral Maxillofac Surg, 38, 571, 10.1054/bjom.2000.0298 Mantel, 2004, Dilution strange and electromyographic guidance in use of botulinum toxins, Dermatolclin, 22, 135